Importantly, semaglutide carries a boxed warning regarding the risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)
Roche is advancing an oral GLP-1 receptor agonist, CT-996, which it gained through its 2024 acquisition of Carmot Therapeutics, a Berkeley, California-based bio/pharmaceutical company, in a deal worth up to $3.1 billion ($2.7 billion at closing plus $400 million in potential milestone payments)
We will explore what these medications are, how they work, and whether hair thinning is a side effect you should be worried about
When the psychological benefits of alcohol are blunted, it helps to reduce cravings by eliminating the positive association
doi: 10.1016/S0140-6736(14)60976-4 232 HannonTSArslanianSA